Product Information

OMEPRAZOLE DR 20 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0312 per EA under NDC 59651000299. Its NADAC has been published 351 times since Mar 4, 2020.

FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OMEPRAZOLE DR 20 MG CAPSULE

Omeprazole
$0.0312per EA

Strength

20 mg/1

NDC

59651000299

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OMEPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA203270

FDA Approved

8/19/2015

TE Code

AB

On Market Since

8/19/2015

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for OMEPRAZOLE DR 20 MG CAPSULE has been published 351 times since Mar 4, 2020, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0312 per EA
All-time high$0.0446 (Mar 11, 2020)
All-time low$0.0265 (Nov 20, 2024)
52-week high$0.0312
52-week low$0.0277
Median price$0.0338
Average price$0.0347
Largest weekly change-25.0% (Apr 17, 2024)
Weeks tracked351
Tracking sinceMar 4, 2020

Price History

1W

+2.3%

1M

+5.8%

3M

+12.6%

6M

+9.0%

1Y

+0.0%

3Y

-5.4%

5Y

-11.1%

All

-30.2%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OMEPRAZOLE DR 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 20 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0312 per EA (NDC 59651000299), effective Nov 18, 2026.

How has the price of OMEPRAZOLE DR 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has declined 30.2%. It has been tracked across 351 weekly CMS publications since Mar 4, 2020.

What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 20 MG CAPSULE?

Since Mar 4, 2020, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has ranged from a low of $0.0265 (Nov 20, 2024) to a high of $0.0446 (Mar 11, 2020), with a median of $0.0338 per EA.

Are there cheaper alternatives to OMEPRAZOLE DR 20 MG CAPSULE?

Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 20 MG CAPSULE, is $0.0277 per EA — about 11% below OMEPRAZOLE DR 20 MG CAPSULE.

Who manufactures OMEPRAZOLE DR 20 MG CAPSULE?

OMEPRAZOLE DR 20 MG CAPSULE (NDC 59651000299) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.